Clinical trial
Evaluation of the Relationship Between Baseline Flortaucipir PET Signal and Cognitive Change in Subjects With Early Alzheimer's Disease Participating in the I8D-MC-AZES Protocol Addendum D5010C00009 (2.1) (Tau Imaging)
NCT03901105 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Relationship Between Baseline Flortaucipir PET Signal and Cognitive Change in Subjects With Early Alzheimer's Disease Participating in the I8D-MC-AZES Protocol Addendum D5010C00009 (2.1) (Tau Imaging)
- Lead sponsor
- Avid Radiopharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 28, 2019
- Completion date
- April 28, 2019
- Enrollment
- 205 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.